Leveraging Accelerometry as a Prognostic Indicator for Increase in Opioid Withdrawal Symptoms
Lambert TP, Gazi AH, Harrison AB, Gharehbaghi S, Chan M, Obideen M, Alavi P, Murrah N, Shallenberger L, Driggers EG, et al.
Biosensors · 2022
Key finding
Treating opioid use disorder (OUD) is a significant healthcare challenge in the United States.
- Condition
- Addiction
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- 23
Cite this study
Lambert, T. P., Gazi, A. H., Harrison, A. B., Gharehbaghi, S., Chan, M., Obideen, M., Alavi, P., Murrah, N., Shallenberger, L., Driggers, E. G., Alvarado Ortega, R., Washington, B., Walton, K. M., Tang, Y. L., Gupta, R., Nye, J. A., Welsh, J. W., Vaccarino, V., Shah, A. J., … Inan, O. T. (2022). Leveraging Accelerometry as a Prognostic Indicator for Increase in Opioid Withdrawal Symptoms. Biosensors, 12(11), 924. https://doi.org/10.3390/bios12110924
Related studies in Addiction
Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature
Young et al. · Journal of addictive diseases · 2020 · Systematic Review / Meta-Analysis
Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study
Gazi et al. · Brain Stimulation · 2022 · Randomised Controlled Trial
Noninvasive vagal nerve stimulation reduces withdrawal-related affective distress and improves functional outcomes in alcohol use disorder - A feasibility and acceptability pilot study
Klaming et al. · Neuromodulation · 2025 · Controlled Clinical Trial
Pupillary response to percutaneous auricular vagus nerve stimulation in alcohol withdrawal syndrome: A pilot trial
Treiber et al. · Alcohol · 2024 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.